CDC
WASHINGTON - CDC has confirmed the influenza neuraminidase N1 subtype of the U.S. case of human avian influenza A(H5) reported last week by genetic sequencing. Genetic characterization is ongoing and final data will be made publicly available in GenBankexternal icon as soon as available.
Background. A person has tested positive for avian influenza A(H5) virus (H5 bird flu) in the U.S., as reported by Colorado and confirmed by CDC. This case occurred in a person who had direct exposure to poultry and was involved in the culling (depopulating) of poultry with presumptive H5N1 bird flu. The patient reported fatigue for a few days as their only symptom and has since recovered. The patient is being isolated and treated with the influenza antiviral drug oseltamivir.
Click here to learn more.
Source: CDC.gov
Latest from Pest Control Technology
- How to Take Advantage of Networking in the Pest Control Industry
- Rat Damage to Vehicles Rises as Temperatures Grow Colder
- CSI: Termites
- Drowning in the Details? Seven Steps to Overcoming the Urge to Micromanage
- Ground Dove Population Increases on Ulong Island Following Removal of Invasive Rats
- Miller Pest Solutions Promotes Keith Johnson to External Operations Director
- Anticimex Carolinas Family of Brands Sponsors Salvation Army Angel Tree Program
- Guest Feature: Insight Canada’s Path to Sustainable Success in Quebec
